Endocare, Inc is a subsidiary of HealthTronics, Inc. Endocare is dedicated to treating cancer with innovative minimally invasive approaches. The current core of its technologies is cryoablation for destruction of tumors in the kidney and lung as well as treating prostate cancer, liver metastases and providing palliative intervention for cancer.
Stop Cancer Cold™
Endocare™ cryoablation therapy is a specialized type of cryotherapy for the minimally invasive treatment of cancer of the prostate, kidney and lung as well as liver metastases and palliative intervention. Prostate salvage cryotherapy is a form of treatment administered when radiation therapy has not been successful and a growing amount of evidence supports the use of cryotherapy for patients with localized prostate cancer following radiation therapy (Jones JS. European Urology 2011; 60:411-412).
Utilization of cryotherapy for the treatment of small tumors of the kidney has also increased in recent years due to the fact that, in addition to urologic cryosurgeons, interventional radiologists can perform cryotherapy with high precision using computerized tomography (CT) scanning under either general anesthesia or conscious sedation.
ENDOCARE is a trademark of Endocare, Inc., registered in the U.S. with the U.S. Patent and Trademark Office and in other countries.